H2BC21 and neoplasm: To assess proliferative heterogeneity of tumor cells, we utilized a genetic label-retaining strategy based on expression of tetracycline-regulated (Tet-off) histone 2B (H2B) green fluorescent protein (GFP) [32] (Figure S2a).